Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2023-08-30 00:00:00 ET · period of report 2023-08-28 · accession 0001209191-23-047749 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-30 | 2023-08-28 | FLGT | Kim Paul | CFO, Treas | S - Sale | $33.62 | -10.3K | 215.6K | -5% | -$346.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-28 | S | D | 10,299 | $33.62 | 215,553 | D | — | — | (F1) The shares were sold in multiple transactions at prices ranging from $33.51 to $33.90, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |